(R)-Naproxen Acyl-β-D-glucuronide is a metabolite of naproxen (sc-200506), a potent inhibitor of Cox-1 and -2.
1. Boynton, C S., et al., 1988. NSAIDs: an overview. Journal of clinical pharmacology. 28(6): 512-7. PMID: 3047176
2. Jin, C., et al., 1993. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. The Journal of pharmacology and experimental therapeutics. 264(1): 475-9. PMID: 8423545
3. King, C., et al., 2001. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicological sciences : an official journal of the Society of Toxicology. 61(1): 49-53. PMID: 11294973
4. Aresta, Antonella., et al., 2005. Determination of naproxen in human urine by solid-phase microextraction coupled to liquid chromatography. Journal of pharmaceutical and biomedical analysis. 39(3-4): 643-7. PMID: 15905065
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.